The antiviral effect of Keishi-ni-eppi-ichi-to, a tranditional Chinese herbal medicine, on influenza A2(H2N2) virus infection in mice

M. A. Ball, T. Utsunomiya, K. Ikemoto, Makiko Kobayashi, R. B. Pollard, Fujio Suzuki

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

The antiviral effect of Keishi-ni-eppi-ichi-to (TJS-064), a traditional Chinese herbal medicine, was investigation in mice infected with influenza A2(H2N2) virus. When mice exposed to 5 LD50 dose of the virus were treated orally with a 70 mg/kg dose of TJS-064 1 day before and 1 day and 4 days after the infection, 100% survived over a 25-day experimental period. At the end of this period all the control mice, treated with saline alone, had died; their mean survival time in days (MSD) was 11.2 days. When mice infected with a 10 LD50 dose of the virus were treated with TJS-064, the MSD was >17.4 days and there was a 50% survival rate, while the control group had a MSD of 8.7 days and 0% survival rate. No significant antiviral effect TJS-064 was observed when the agent was administered orally to mice infected with a 100 LD50 or large dose of influenza virus. Pulmonary consolidation, virus titers in lung tissues and HAI titers in sera of infected mice treated with TJS-064 were all significantly lower than those of infected mice treated with saline. Interferon activities were detected in sera of mice treated with the agent at a dose of 100 mg/kg orally. Since viricidal and viristatic activities of the agent against influenza virus were not demonstrated, the antiviral effects of TJS-064 may be expressed through the host's antiviral functions including interferon production.

Original languageEnglish (US)
Pages (from-to)774-779
Number of pages6
JournalExperientia
Volume50
Issue number8
DOIs
StatePublished - Aug 1994

Fingerprint

H2N2 Subtype Influenza A Virus
Herbal Medicine
Virus Diseases
Viruses
varespladib methyl
Human Influenza
Antiviral Agents
Lethal Dose 50
Interferons
Orthomyxoviridae
Lung
keishi-ni-eppi-ichi-to
Consolidation
Viral Load
Serum
Tissue

Keywords

  • a mouse model
  • antiviral effect
  • influenza virus
  • Traditional Chinese herbal medicine

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

The antiviral effect of Keishi-ni-eppi-ichi-to, a tranditional Chinese herbal medicine, on influenza A2(H2N2) virus infection in mice. / Ball, M. A.; Utsunomiya, T.; Ikemoto, K.; Kobayashi, Makiko; Pollard, R. B.; Suzuki, Fujio.

In: Experientia, Vol. 50, No. 8, 08.1994, p. 774-779.

Research output: Contribution to journalArticle

Ball, M. A. ; Utsunomiya, T. ; Ikemoto, K. ; Kobayashi, Makiko ; Pollard, R. B. ; Suzuki, Fujio. / The antiviral effect of Keishi-ni-eppi-ichi-to, a tranditional Chinese herbal medicine, on influenza A2(H2N2) virus infection in mice. In: Experientia. 1994 ; Vol. 50, No. 8. pp. 774-779.
@article{936a265b0cc34bde9da9be8e7394f99a,
title = "The antiviral effect of Keishi-ni-eppi-ichi-to, a tranditional Chinese herbal medicine, on influenza A2(H2N2) virus infection in mice",
abstract = "The antiviral effect of Keishi-ni-eppi-ichi-to (TJS-064), a traditional Chinese herbal medicine, was investigation in mice infected with influenza A2(H2N2) virus. When mice exposed to 5 LD50 dose of the virus were treated orally with a 70 mg/kg dose of TJS-064 1 day before and 1 day and 4 days after the infection, 100{\%} survived over a 25-day experimental period. At the end of this period all the control mice, treated with saline alone, had died; their mean survival time in days (MSD) was 11.2 days. When mice infected with a 10 LD50 dose of the virus were treated with TJS-064, the MSD was >17.4 days and there was a 50{\%} survival rate, while the control group had a MSD of 8.7 days and 0{\%} survival rate. No significant antiviral effect TJS-064 was observed when the agent was administered orally to mice infected with a 100 LD50 or large dose of influenza virus. Pulmonary consolidation, virus titers in lung tissues and HAI titers in sera of infected mice treated with TJS-064 were all significantly lower than those of infected mice treated with saline. Interferon activities were detected in sera of mice treated with the agent at a dose of 100 mg/kg orally. Since viricidal and viristatic activities of the agent against influenza virus were not demonstrated, the antiviral effects of TJS-064 may be expressed through the host's antiviral functions including interferon production.",
keywords = "a mouse model, antiviral effect, influenza virus, Traditional Chinese herbal medicine",
author = "Ball, {M. A.} and T. Utsunomiya and K. Ikemoto and Makiko Kobayashi and Pollard, {R. B.} and Fujio Suzuki",
year = "1994",
month = "8",
doi = "10.1007/BF01919381",
language = "English (US)",
volume = "50",
pages = "774--779",
journal = "Experientia",
issn = "0014-4754",
publisher = "Birkhauser Verlag Basel",
number = "8",

}

TY - JOUR

T1 - The antiviral effect of Keishi-ni-eppi-ichi-to, a tranditional Chinese herbal medicine, on influenza A2(H2N2) virus infection in mice

AU - Ball, M. A.

AU - Utsunomiya, T.

AU - Ikemoto, K.

AU - Kobayashi, Makiko

AU - Pollard, R. B.

AU - Suzuki, Fujio

PY - 1994/8

Y1 - 1994/8

N2 - The antiviral effect of Keishi-ni-eppi-ichi-to (TJS-064), a traditional Chinese herbal medicine, was investigation in mice infected with influenza A2(H2N2) virus. When mice exposed to 5 LD50 dose of the virus were treated orally with a 70 mg/kg dose of TJS-064 1 day before and 1 day and 4 days after the infection, 100% survived over a 25-day experimental period. At the end of this period all the control mice, treated with saline alone, had died; their mean survival time in days (MSD) was 11.2 days. When mice infected with a 10 LD50 dose of the virus were treated with TJS-064, the MSD was >17.4 days and there was a 50% survival rate, while the control group had a MSD of 8.7 days and 0% survival rate. No significant antiviral effect TJS-064 was observed when the agent was administered orally to mice infected with a 100 LD50 or large dose of influenza virus. Pulmonary consolidation, virus titers in lung tissues and HAI titers in sera of infected mice treated with TJS-064 were all significantly lower than those of infected mice treated with saline. Interferon activities were detected in sera of mice treated with the agent at a dose of 100 mg/kg orally. Since viricidal and viristatic activities of the agent against influenza virus were not demonstrated, the antiviral effects of TJS-064 may be expressed through the host's antiviral functions including interferon production.

AB - The antiviral effect of Keishi-ni-eppi-ichi-to (TJS-064), a traditional Chinese herbal medicine, was investigation in mice infected with influenza A2(H2N2) virus. When mice exposed to 5 LD50 dose of the virus were treated orally with a 70 mg/kg dose of TJS-064 1 day before and 1 day and 4 days after the infection, 100% survived over a 25-day experimental period. At the end of this period all the control mice, treated with saline alone, had died; their mean survival time in days (MSD) was 11.2 days. When mice infected with a 10 LD50 dose of the virus were treated with TJS-064, the MSD was >17.4 days and there was a 50% survival rate, while the control group had a MSD of 8.7 days and 0% survival rate. No significant antiviral effect TJS-064 was observed when the agent was administered orally to mice infected with a 100 LD50 or large dose of influenza virus. Pulmonary consolidation, virus titers in lung tissues and HAI titers in sera of infected mice treated with TJS-064 were all significantly lower than those of infected mice treated with saline. Interferon activities were detected in sera of mice treated with the agent at a dose of 100 mg/kg orally. Since viricidal and viristatic activities of the agent against influenza virus were not demonstrated, the antiviral effects of TJS-064 may be expressed through the host's antiviral functions including interferon production.

KW - a mouse model

KW - antiviral effect

KW - influenza virus

KW - Traditional Chinese herbal medicine

UR - http://www.scopus.com/inward/record.url?scp=0028108311&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028108311&partnerID=8YFLogxK

U2 - 10.1007/BF01919381

DO - 10.1007/BF01919381

M3 - Article

VL - 50

SP - 774

EP - 779

JO - Experientia

JF - Experientia

SN - 0014-4754

IS - 8

ER -